INTRODUCTION
============

Plant secondary metabolites play multiple roles in the interaction between plants and their environment ([@B17]). Almost 100,000 secondary metabolites have been discovered from plant species ([@B72]; [@B35]; [@B1]). Alkaloids are organic nitrogenous bases, usually in a heterocyclic ring, with characteristic toxicity and marked pharmacological effects in humans and animals ([@B15]). Alkaloids are derived from the products of primary metabolism, with amino acids, such as Phe, Tyr, Trp, Orn, and Lys, serving as their main precursors ([@B22]). Approximately 20% of plant species accumulate alkaloids and over 12,000 different alkaloids have been described, suggesting higher structural and biosynthetic diversity compared to other secondary metabolites ([@B12]; [@B15]).

Alkaloids derived from Lys are widely distributed throughout the plant kingdom and are subdivided into piperidine, quinolizidine, indolizidine, and lycopodium alkaloids. Piperidine alkaloids are found in plants in the order Piperales (e.g., piperine from *Piper nigrum*), Myrtales (e.g., (--)-pelletierine from *Punica granatum*), and Asterales (e.g., (--)-lobeline from *Lobelia inflata*). Quinolizidine (e.g., (--)-lupinine and (--)-sparteine from *Lupinus luteus* and *Cytisus scoparius*, respectively) and indolizidine (e.g., (--)-swainsonine from *Swainsona canescens*) alkaloids are found mainly in the order *Fabales* ([@B45], [@B46]; [@B11]; [@B67]; [@B48]; [@B24]). Lycopodium alkaloids (e.g., (--)-huperzine A and lycopodine from *Huperzia serrata*) are found mainly in the genus *Lycopodium* (**Figure [1](#F1){ref-type="fig"}**; [@B41]; [@B43]). Several alkaloids have beneficial properties for humans and are used in medicine. For example, (--)-lobeline is used in the treatment of central nervous system disorders and drug abuse and (--)-huperzine A is used in the treatment of Alzheimer's disease ([@B14]; [@B5]; [@B19]; [@B18]).

![**Biosynthesis of universal intermediates, skeleton structures, and some Lys-derived alkaloids found in plants**. Piperine, (--)-pelletierine, and (--)-lobeline are piperidine alkaloids. (--)-Lupinine and (--)-sparteine are quinolizidine alkaloids. (--)-Swainsonine is an indolizine alkaloids. Lycopodine and (--)-huperzine A are lycopodium alkaloids. LDC, Lys decarboxylase; CuAO, copper amine oxidase.](fpls-03-00239-g001){#F1}

Over the past decade, intensive efforts have been made to identify the genes encoding the enzymes involved in the biosynthesis of isoquinoline, indole, tropane, and purine alkaloids ([@B12]; [@B23]). However, the molecular mechanisms underlying the biosynthesis of Lys-derived alkaloids are poorly understood. In this article, we discuss recent advances in our understanding of the Lys-derived alkaloids, especially the genes involved in the quinolizidine alkaloid (QA) biosynthetic pathway. We highlight the novel finding of Lys decarboxylase (LDC) from plants and discuss how it evolved from primary metabolism to alkaloid biosynthesis. Finally, we consider how to apply current advanced technologies to the study of unidentified alkaloid biosynthetic pathways.

BIOSYNTHESIS OF LYS-DERIVED ALKALOIDS
=====================================

L-Lys is the homologue of L-Orn, a precursor of pyrrolidine, tropane, and pyrrolizidine alkaloids. The extra methylene group in Lys participates in forming 6-membered piperidine rings, while Orn participates in forming 5-membered pyrrolizidine rings ([@B16]; [@B56]). Biosynthetic pathways of several potential Lys-derived alkaloids have been proposed based on tracer experiments with labeled precursors ([@B38] and references therein). Feeding studies demonstrated that the first step in piperidine, quinolizidine, and lycopodium alkaloid biosynthesis is the decarboxylation of L-Lys into cadaverine by LDC (EC 4.1.1.18). Oxidative deamination of cadaverine by copper amine oxidase (CuAO, EC 1.4.3.22) yields 5-aminopentanal, which is spontaneously cyclized to Δ^1^-piperideine Schiff base ([@B38]; [@B28]; [@B27]; [@B60]; [@B43]). In contrast, indolizidine alkaloids are formed from L-Lys via L-pipecolic acid which is formed via the aldehyde and Schiff base, with retention of the nitrogen of the α-amino acid group (**Figure [1](#F1){ref-type="fig"}**; [@B29],[@B30]; [@B73]; [@B16]). Δ^1^-Piperideine and L-pipecolic acid are universal intermediates that can be modified by condensation, hydrolysis, or methylation to produce diverse Lys-derived alkaloids (**Figure [1](#F1){ref-type="fig"}**; [@B21]).

The genes and enzymes involved in the biosynthesis of Lys-derived alkaloids are not well documented. The best-studied pathway at the genetic level is the one leading to the formation of QAs, which will be discussed in the following section. One other study addresses partially purified piperoyl-CoA: piperidine *N*-piperoyltransferase (EC 2.3.1.145) from*P. nigrum*which catalyzes the synthesis of piperine in the presence of piperoyl-CoA and piperidine ([@B26]).

QUINOLIZIDINE ALKALOIDS
=======================

Quinolizidine alkaloids are a group of alkaloids possessing a quinolizidine ring or a piperidine ring ([@B60]). QAs occur mainly in the family Leguminosae, especially in the genera *Lupinus*, *Baptisia*, *Thermopsis*, *Genista*, *Cytisus*, and *Sophora*([@B50]). More than 500 *Lupinus* species have been described and 200--300 species are distributed in North and South America ([@B79]). QAs are important as potential sources of medicine. They have a broad range of pharmacological properties, including cytotoxic, oxytocic, antipyretic, antibacterial, antiviral, and hypoglycemic activities, as determined by *in vivo* pharmacological screening ([@B60]). Some QA-containing plants, for example *Sophora flavescens,* have been used as sources of crude drugs in Chinese--Japanese medicine (KAMPO; [@B71]).

Quinolizidine alkaloids are synthesized through the cyclization of the cadaverine unit ([@B27]), which is produced through the action of LDC (**Figure [2](#F2){ref-type="fig"}**; [@B60]). Various QA skeletons are further modified by tailoring reactions (e.g., dehydrogenation, oxygenation, or esterification) to yield several hundred structurally related alkaloids ([@B50]). *Lupinus* accumulates two types of QA esters, the derivatives of lupinine and lupanine. QA esters are assumed to be end products of biosynthesis and storage forms ([@B50]). Two acyltransferases (ATs) involved in QA ester biosynthesis have been identified and characterized: (--)-13α-hydroxymultiflorine/(+)-13α-hydroxylupanine *O*-tigloyltransferase (HMT/HLT; EC 2.3.1.93), which catalyzes the transfer of the tigloyl group from tigloyl-CoA to (--)-13α-hydroxymultiflorine or (+)-13α-hydroxylupanine, and *p*-coumaroyl-CoA/feruloyl-CoA: (+)-epilupinine/(--)-lupinine *O*-coumaroyl/feruloyltransferase (ECT/EFT-LCT/LFT), which catalyzes the transfer of *p*-coumaroyl-CoA or feruloyl-CoA to the hydroxyl moiety of (+)-epilupinine or (--)-lupinine (**Figure [2](#F2){ref-type="fig"}**; [@B61], [@B58]; [@B70]). However, only HMT/HLT has been cloned and characterized at the molecular level ([@B51]). HMT/HLT belongs to the BAHD super family, a plant acyl-CoA-dependent AT gene family that transfers acyl groups from their CoA esters to various plant metabolites ([@B13]).

![**Biosynthetic pathway of quinolizidine alkaloids**. Quinolizidine alkaloids are synthesized by the decarboxylation of Lys, yielding cadaverine, which is further modified by various reactions as shown. The metabolites derived from the pathway are shown. Enzymes involved in the synthesis of these alkaloids are indicated: LDC, Lys decarboxylase; HMT/HLT, tigloyl-CoA: (--)-13α-hydroxymultiflorine/(+)-13α-hydroxylupanine*O*-tigloyltransferase; ECT/EFT-LCT/LFT, *p*-coumaroyl-CoA/feruloyl-CoA: (+)-epilupinine/(--)-lupinine *O*-coumaroyl/feruloyltransferase.](fpls-03-00239-g002){#F2}

An investigation of an alkaloid-rich "bitter" cultivar and an alkaloid-poor "sweet" cultivar of *L. angustifolius* using random amplified polymorphic DNA (RAPD) showed that total DNA polymorphisms did not differ substantially between the two cultivars ([@B34]). A cDNA-amplified fragment length polymorphism (cDNA-AFLP) was then used to isolate the genes specifically expressed in the bitter plant; however, no bitter-specific gene was isolated ([@B34]). The PCR-select subtraction technique was then used to profile differentially expressed genes in the two cultivars. Among 71 bitter-specific fragments, three genes exhibited homologies to Orn decarboxylase (ODC, EC 4.1.1.17), CuAO, and AT, representing potential candidates for structural genes encoding QA biosynthetic enzymes ([@B9]). Further study showed that the AT might be involved either in the formation of QA esters or*N*-acylated polyamine conjugates ([@B9]) and ODC was identified as Lys/Orn decarboxylase (L/ODC; see below) ([@B8]). In addition, partial sequences encoding candidate transcription factors that might regulate the expression of genes in QA biosynthesis were obtained; these included DNA binding protein EREBP-3, leucine zipper protein, and coronatine-insensitive 1, which provide clues about the regulation of the QA biosynthetic pathway ([@B9]). Genomic PCR of *L*. *angustifolius* AT and LDC indicated the presence of at least one copy of both genes in the genomes of both the bitter and sweet cultivars. However, transcripts of both genes were expressed only in the bitter cultivar. This finding is interesting in terms of the regulation of the entire QA biosynthetic pathway ([@B9], [@B8]).

A NOVEL LYS DECARBOXYLASE FROM QUINOLIZIDINE ALKALOIDS PRODUCING PLANTS
=======================================================================

Lys decarboxylase and ODC are key enzymes involved in the formation of cadaverine and putrescine by the decarboxylation of Lys and Orn, respectively. Cadaverine, putrescine, and other aliphatic polyamines, such as spermidine and spermine, are involved in a number of growth and developmental processes ([@B4]). Unlike plant ODCs, plant LDCs have not been well studied at the molecular level. There are several studies on crude protein extracts or partially purified protein extracts from *Glycine max*([@B36]; [@B49]) and *L. polyphyllus*([@B31]). There was speculation that a member of group IV of the PLP-dependent amino acid decarboxylases might be responsible for the production of cadaverine from Lys ([@B64]) and that ODC may also have LDC activity in plants that make cadaverine-derived alkaloids ([@B66]).

Recently, we isolated a cDNA of L/ODC from *L*. *angustifolius* (*La-L/ODC*) using differential transcript screening in QA-producing and non-producing cultivars ([@B9], [@B8]). We also obtained *L/ODCs*cDNAs from *S*. *flavescens* and *Echinosophora koreensis*, which also produce QAs. Recombinant L/ODCs from QA-producing plants almost equally catalyzed the decarboxylation of L-Lys and L-Orn unlike the known ODCs that only accept Orn ([@B6]; [@B8]). *In vivo* experiments of *La-L/ODC*expression in *Arabidopsis thaliana* and *Nicotiana tabacum* provided evidence that this enzyme is involved in the first step of QA biosynthesis ([@B8]). This is the first plant LDC identified at the molecular level by cDNA cloning and the second QA biosynthesis enzyme for which the cDNA has been identified.

Identification of La-L/ODC answers a longstanding question about the molecular entity of LDC activity in plants. We found LDCs in plant species that produce QAs. A point mutation from His-344 to Phe-344 (La-L/ODC numbering) is key for La-L/ODC to exhibit substrate promiscuity for Lys and Orn. This amino acid substitution has presumably occurred via adaptive evolution of LDC within the QA-producing plants to expand substrate accessibility to Lys ([@B8]). These results reveal how plants have been opportunistic in adapting primary metabolic processes to permit the diversification of secondary metabolism, in this case, substrate promiscuity. Accordingly, the mutation in this position may be found not only in QA-producing Leguminosae but also in plants that produce cadaverine-derived alkaloids. This finding is a breakthrough in the understanding of both QA biosynthesis and LDC occurrence and function in plants.

A major safety issue of lupine-based foods is the presence of QAs, which are toxic to human and mammals. Genetic mapping of *L*. *angustifolius* and *L. albus*has been completed, which enables the mapping of the genes controlling key domestication traits, including alkaloid production, water permeability, flowering time, pod shattering, pigment production in seeds, and anthracnose resistance ([@B7]; [@B47]; [@B54]). This information will be useful not only to the *Lupinus*research community but also to other legume research communities studying molecular breeding and evolution in leguminous plants. The identified La-L/ODC provides a good candidate enzyme as an entry-point enzyme of QA biosynthesis for metabolic engineering to manipulate the production of QAs.

COMPARTMENTALIZATION AND SUBCELLULAR LOCALIZATION
=================================================

The subcellular compartmentalization of alkaloid biosynthetic enzymes is as complex as the cell type-specific localization of gene transcripts, enzymes, and metabolites ([@B83]). The majority of QAs are synthesized in shoot tissues. Of the QAs that accumulate in seeds, half are synthesized *in situ* and half are translocated primarily by phloem ([@B37]). The concentration of QAs in seeds decreases during germination and development and increases as soon as new leaves are formed ([@B78]). The biosynthesis of QAs occurs mainly in the green parts of plants where the enzymes for Lys, cadaverine, and lupanine synthesis are present ([@B75], [@B76]; [@B77]). La-L/ODC is localized in chloroplasts, while HMT/HLT localized in mitochondria. ECT is assumed to be present in another organelle, but not in mitochondria ([@B69]; [@B8]).

ENGINEERING IN QA-PRODUCING PLANTS
==================================

The concentration of QAs in cell suspension cultures of *Lupinus* and related plants is approximately 100--1000 times lower than that of concentration in leaves of differentiated plants ([@B31]; [@B32]). In cell suspension cultures, the storage tissue is probably repressed; thus, the QAs cannot be stored in large quantities and are degraded rapidly either inside the cells or in the cell culture medium ([@B74]). In callus, the concentration of QAs is correlated to the amount of chlorophyll in the cells ([@B62],[@B63]).

*Lupinus*spp. are the major grain legumes in Australia and have been used as feed supplements. In the past decade, they have gained attention as ingredients for human food because of their high percentage of protein (34--43% of dry matter) and acceptable content of essential amino acids ([@B68]). To genetically engineer plants successfully, a routine transformation system is needed. Thus, it is necessary to develop a transformation system for *Lupinus* lines to confer desired traits, such as herbicide resistance, resistance to certain pathogens, increased pod and seed set, and improved seed quality ([@B55]). Many transformation systems for *Lupinus* sp. have been developed; however, only a few have been successful. For example, shoot regeneration using *Agrobacterium*-mediated gene transfer to preorganized meristematic tissue combined with axillary regeneration has been successful in *L*. *angustifolius*([@B55]), *L. luteus*([@B39]), and *L. mutabilis*([@B3]). However, transformation efficiency is poor and transformation in some *Lupinus* species and even in different cultivars of the same species is difficult. In *L*. *mutabilis*, the transformed roots synthesize isoflavones, but not QAs ([@B2]). Genetic engineering of *L. angustifolius* by over expressed *sun flower seed albumin* gene has succeeded to enhance methionine levels and increase nutritive value of seeds of transgenic *Lupinus* plants ([@B44]).

FUTURE PROSPECTS
================

In the past few years, progress has been made in the elucidation of alkaloid biosynthetic pathways and their regulation. However, only two genes, HMT/HLT and L/ODC, have been isolated and characterized so far. Rapid progress in the development of integrative approaches, such as genomics, transcriptomics, proteomics, and metabolomics, has provided essential information for the understanding of many complex biological processes at different levels ([@B25]; [@B81]). Comparative and integrative analyses of such "omics" data will facilitate the determination of gene function and pinpoint rate limiting steps and factors in the biosynthetic pathway of secondary metabolites. Transcriptomic and metabolomic approaches, particularly transcriptome coexpression network analysis, have been used to identify genes involved in specific pathways not only in *Arabidopsis*but also in crops and medicinal plants. Such strategies have proven to be useful in fundamental plant biology and applied biotechnology ([@B84]; [@B33]; [@B57]: [@B65]; [@B82], [@B80]; [@B40]; [@B52]; [@B59]; [@B53]).

Advances in sequencing technology, next-generation sequencing, and computer technology for processing of large data sets are opening a new era in plant science. It is estimated that the cost of DNA sequencing drops at a faster rate than the cost of computer data processing ([@B20]). Therefore, the development of sequencing techniques with high-throughput will likely be applied to alkaloid-producing plants and provide the basis for many sequence-based approaches that are now limited to model plants such as *Arabidopsis* and rice ([@B83]). Today, many researchers are making progress in plant genome and transcriptome sequencing. For instance, the 1KP project aims to generate large-scale gene sequence information for 1000 different plants, including a wide variety of species from algae to land and aquatic plants, to understand the vast biodiversity that has barely been touched by genomics to date^[1](#fn01){ref-type="fn"}^. In addition, the medicinal plant consortium project focuses on providing transcriptomic and metabolic resources for 14 key medicinal plants, for instance *Atropa belladonna* and *Camptotheca acuminata*, to the worldwide research community for the advancement of drug production and development^[2](#fn02){ref-type="fn"}^. Recently, we started the deep transcriptome sequencing of Japanese medicinal plants and both cultivars of *L. angustifolius* to obtain more information about the enzymes and transcription factors involved in the production of plant secondary metabolites. Such publicly accessible databases will provide novel information for the research community and ultimately accelerate the progress of the study of plant science.

The predicted function or *in vitro* characterization of alkaloid biosynthetic enzymes and other components must be confirmed *in vivo* ([@B83]). However, there is no reliable and highly efficient transformation protocol for *Lupinus* and related plants. Virus induced gene silencing (VIGS), a technology that exploits an RNA-mediated antiviral defense mechanism, is a fast method for the generation of transient transformed plants ([@B42]). VIGS has been used widely in plants for analysis of gene function and has been adapted for high-throughput functional genomics ([@B10]). Thus, VIGS might be a powerful tool for assessing and characterizing the function of candidate genes in the QA biosynthetic pathway. Further investigations on inter- and intracellular transport of pathway intermediates and products and on cellular and subcellular localization of enzymes are also important because they are crucial factors in controlling the accumulation of target metabolites in plants ([@B23]).

CONCLUSION
==========

Knowledge of the biosynthetic pathway of Lys-derived alkaloids is limited. The best-studied pathway at the genetic level is QA biosynthesis; however, only two genes have been identified. Application of current technologies, such as next-generation sequencing, high-end proteomics, and metabolomics approaches, is needed to study secondary metabolic pathways for a better understanding of metabolic networks. Such information will aid in the development of successful strategies in genetic engineering of secondary metabolites in plants.
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